← SynDRA
E2012
SynDRA canonical compound SYN1959607 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | APH1A | APH1B | APP | PSENEN |
|---|
| Mechanism of action | gamma secretase modulator |
|---|
All known targets
- APH1A
- APH1A; APH1B; NCSTN; PSENEN; PSEN1
- APH1B
- APP
- PSENEN
Mechanisms of action (all sources)
- gamma secretase modulator
- Modulator
Cross-references
Synonyms
- E-2012
- (E)-1-[(1S)-1-(4-FLUOROPHENYL)ETHYL]-3-[3-METHOXY-4-(4-METHYL-1H-IMIDAZOL-1-YL)BENZYLIDENE]PIPERIDIN-2-ONE
- UNII-3LSD4Y5F0F
- 3LSD4Y5F0F
- CHEMBL1224151
- J-501810
- (3E)-1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]piperidin-2-one
- (e)-1-((1s)-1-(4-fluorophenyl)ethyl)-3-(3-methoxy-4-(4-methyl-1h-imidazol-1-yl)benzylidene)piperidin-2-one
- PUOAETJYKQITMO-LANLRWRYSA-N
Look up E2012 in the interactive SynDRA portal →